Capitolis Liquid Global Markets’s Elevance Health ELV Stock Holding History

Capitolis Liquid Global Markets’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$151M	Sell	387,985 -226,205	-37%	-$90.3M	0.67%	30
2026 Q2	$238M	Buy	614,190 +549,152	+844%	+$204M	1.03%	26
2026 Q1	$19M	Sell	65,038 -9,962	-13%	-$3.27M	0.12%	134
2025 Q4	$26.3M	Buy	75,000 +37,000	+97%	+$12.5M	0.16%	100
2025 Q3	$12.3M	Hold	38,000	–	–	0.1%	125
2025 Q2	$14.8M	Sell	38,000 -7,000	-16%	-$2.82M	0.11%	124
2025 Q1	$19.6M	Hold	45,000	–	–	0.17%	85
2024 Q4	$16.6M	Buy	+45,000	New	+$18.8M	0.16%	68

Other funds holding ELV

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Capitolis Liquid Global Markets's ELV Position: Q3 2026 in Review

Capitolis Liquid Global Markets reduced its Elevance Health (ELV) stake by 37% in Q3 2026, selling an estimated $90.3M and leaving 387,985 shares worth $151M. The position accounts for 0.67% of the portfolio, ranked #30.

Capitolis Liquid Global Markets first reported a position in ELV in Q4 2024 and has held it in 8 quarters since. The position peaked at $238M in Q2 2026. 1,306 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Capitolis Liquid Global Markets held 387,985 shares of Elevance Health worth $151M as of Q3 2026.
Capitolis Liquid Global Markets sold 226,205 Elevance Health shares in Q3 2026, an estimated $90.3M.
Elevance Health made up 0.67% of Capitolis Liquid Global Markets's portfolio in Q3 2026, its #30 holding.
Capitolis Liquid Global Markets first reported a position in Elevance Health in Q4 2024 and has held it in 8 quarters since.
Capitolis Liquid Global Markets's Elevance Health position peaked at $238M in Q2 2026.
1,306 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q3 2026, filed 12 Nov 2026.